Xeno Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Xeno Diagnostics's estimated annual revenue is currently $1.7M per year.
- Xeno Diagnostics's estimated revenue per employee is $155,000
Employee Data
- Xeno Diagnostics has 11 Employees.
- Xeno Diagnostics grew their employee count by -27% last year.
Xeno Diagnostics's People
Name | Title | Email/Phone |
---|---|---|
1 | President | Reveal Email/Phone |
Xeno Diagnostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | -17% | N/A | N/A |
#2 | $5.7M | 37 | 6% | N/A | N/A |
#3 | $10.2M | 66 | 6% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.6M | 49 | -2% | N/A | N/A |
#7 | $0.8M | 5 | -17% | N/A | N/A |
#8 | $7.9M | 51 | 6% | N/A | N/A |
#9 | $37.7M | 243 | -2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Xeno Diagnostics?
Xeno Diagnostics, located in Indianapolis, Indiana, was established in 2007 with the primary goal of advancing translational medicine by creating products and testing services to support research in animal models of disease. Since its inception, Xeno has evolved into a highly capable research and development establishment offering a wide variety of in vitro diagnostic services. Xeno Diagnostics has been successful in many areas, from running preclinical research studies to perfecting umbilical stem cell enumeration assays. Our unique history has also led to many business partnerships, again furthering our abilities. To learn more about our products and services, visit us online at www.xenodiagnostics.com, or give us a call at (317) 973-4079. We look forward to hearing from you.
keywords:N/AN/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
-27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 11 | -8% | N/A |
#2 | $1M | 11 | N/A | N/A |
#3 | $1M | 11 | -21% | N/A |
#4 | $1.7M | 11 | -78% | N/A |
#5 | $1M | 11 | -27% | N/A |